Introducing IPC’s Newest Councilors

Please join us in warmly welcoming Daniela Armijo, Ncoza Dlova, Benjamín Hidalgo Matlock, and Wilson Liao as IPC’s newest Councilors for 2023. Their appointment by the IPC Board of Directors in June is a testament to their unwavering dedication to psoriasis and their commitment to enhancing patient care for individuals worldwide affected by this condition.

As esteemed IPC Councilors, these experts will play a crucial role as trusted advisors, offering their invaluable global expertise in psoriasis research, treatment, and education. Their immense support will strengthen all IPC programs, events, and initiatives, ensuring we continue to make significant strides in the field.

To gain deeper insights into the backgrounds of our newest Councilors, we encourage you to read their comprehensive biographies. By doing so, you will discover the wealth of knowledge and experience they bring. We are confident that their contributions will significantly aid us in fulfilling our mission of advancing psoriasis care globally.

We are thrilled to have Daniela Armijo, Ncoza Dlova, Benjamín Hidalgo Matlock, and Wilson Liao join our esteemed community of IPC Councilors. Together, we will continue positively impacting and driving progress in psoriasis care worldwide.

Daniela Armijo, MD

Clínica Dermacross

Santiago, Chile

IPC Councilor

Bio

Ncoza Noxolo Dlova, MD, PhD

University of KwaZulu Natal

Durban, South Africa

IPC Councilor

Bio

Benjamin Hidalgo Matlock, MD

Universidad de Costa Rica / Universidad Latina de Costa Rica, Hospital Nacional de Niños, and Skin Care Physicians of Costa Rica

San Jose, Costa Rica

IPC Councilor

Bio

Wilson Liao, MD

University of California San Francisco

San Francisco, California, United States

IPC Councilor

Bio